日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Enhanced immunogenic potential of cancer immunotherapy antibodies in human IgG1 transgenic mice

人类IgG1转基因小鼠中癌症免疫治疗抗体的免疫原性增强

Jerome Egli ,Stefan Heiler ,Felix Weber ,Guido Steiner ,Timo Schwandt ,Katharine Bray-French ,Christian Klein ,Sebastian Fenn ,Gregor P Lotz ,Eugenia Opolka-Hoffmann ,Thomas E Kraft ,Laetitia Petersen ,Rebecca Moser ,Jonathan DeGeer ,Michel Siegel ,Daniela Finke ,Juliana Bessa ,Antonio Iglesias

DutaFabs are engineered therapeutic Fab fragments that can bind two targets simultaneously

DutaFabs 是经过设计的治疗性 Fab 片段,可以同时结合两个靶标

Roland Beckmann, Kristian Jensen, Sebastian Fenn, Janina Speck, Katrin Krause, Anastasia Meier, Melanie Röth, Sascha Fauser, Raymond Kimbung, Derek T Logan, Martin Steegmaier, Hubert Kettenberger

DuoMab: a novel CrossMab-based IgG-derived antibody format for enhanced antibody-dependent cell-mediated cytotoxicity

DuoMab:一种基于 CrossMab 的新型 IgG 衍生抗体形式,可增强抗体依赖性细胞介导的细胞毒性

Claudio Sustmann, Steffen Dickopf, Jörg T Regula, Hubert Kettenberger, Michael Mølhøj, Christian Gassner, Diana Weininger, Sebastian Fenn, Tobias Manigold, Lothar Kling, Klaus-Peter Künkele, Manfred Schwaiger, Birgit Bossenmaier, Julia J Griese, Karl-Peter Hopfner, Alexandra Graff-Meyer, Henning Sta

Structure of Actin-related protein 8 and its contribution to nucleosome binding

肌动蛋白相关蛋白 8 的结构及其对核小体结合的贡献

Christian B Gerhold, Duane D Winkler, Kristina Lakomek, Florian U Seifert, Sebastian Fenn, Brigitte Kessler, Gregor Witte, Karolin Luger, Karl-Peter Hopfner

Structural biochemistry of nuclear actin-related proteins 4 and 8 reveals their interaction with actin

核肌动蛋白相关蛋白 4 和 8 的结构生物化学揭示了它们与肌动蛋白的相互作用

Sebastian Fenn, Dennis Breitsprecher, Christian B Gerhold, Gregor Witte, Jan Faix, Karl-Peter Hopfner